Related Experiment Video
Updated: Jun 13, 2026
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Cardiovascular aspects of sexual medicine
Graham Jackson1, Piero Montorsi, Michael A Adams
1Guy's & St Thomas' Hospitals NHS Trust, Cardiology, London, UK. gjcardiol@talk21.com
Insights
Erectile dysfunction (ED) is a significant indicator of underlying coronary artery disease (CAD), often preceding symptoms by 3-5 years. Safe and effective treatments for ED in cardiac patients are available following established guidelines.
Area of Science:
- Cardiovascular Medicine
- Urology
- Vascular Biology
Background:
- Erectile dysfunction (ED) is a prevalent condition, primarily recognized for its vascular origins.
- A strong association exists between ED and coronary artery disease (CAD), with 50-70% of men with CAD experiencing ED.
Framework:
- The consensus report synthesizes global literature on ED and CAD, establishing a guideline for clinical management.
- Expert opinion was derived from evidence-based medical literature, committee discussions, and public debate.
Implementation:
- ED frequently precedes symptomatic CAD by 3-5 years, highlighting its role as an early warning sign.
- Shared risk factors and endothelial dysfunction are the common pathophysiological links between ED and CAD.
Implications:
- ED serves as a crucial marker for identifying silent CAD, necessitating its exclusion in affected individuals.
- Management of ED in patients with CAD is safe when guided by established protocols, emphasizing risk assessment.
Introduction:
Erectile dysfunction (ED) is common and considered to be predominantly of vascular origin.
Aim:
To evaluate the link between ED and coronary artery disease (CAD) and provide a consensus report regarding evaluation and management.
Methods:
A committee of eight experts from six countries was convened to review the worldwide literature concerning ED and CAD and provide a guideline for management.
Main Outcome Measure:
Expert opinion was based on grading the evidence-based medical literature, widespread internal committee discussion, public presentation, and debate.
Results:
ED and CAD frequently coexist. Between 50-70% of men with CAD have ED. ED can arise before CAD is symptomatic with a time window of 3-5 years. ED and CAD share the same risk factors, and endothelial dysfunction is the common denominator. Treating ED in cardiac patients is safe, provided that their risks are properly evaluated.
Conclusion:
ED is a marker for silent CAD that needs to be excluded. Men with CAD frequently have ED that can be treated safely following guidelines.
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:20Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:29Pathophysiology of Cardiac Performance
01:17Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:29Assessment of the Cardiovascular System II: Inspection
Head and Neck